|1.||Fontcuberta, Jordi: 3 articles (03/2009 - 05/2007)|
|2.||Corral, Javier: 2 articles (03/2009 - 05/2007)|
|3.||Vicente, Vicente: 2 articles (03/2009 - 05/2007)|
|4.||Tang, Mei-qing: 1 article (09/2010)|
|5.||Tang, Xiang-qi: 1 article (09/2010)|
|6.||Shu, Chang: 1 article (09/2010)|
|7.||Tan, Li-ming: 1 article (09/2010)|
|8.||Tang, Yang-ming: 1 article (09/2010)|
|9.||Zhang, Guang-sen: 1 article (09/2010)|
|10.||Deng, Ming-yang: 1 article (09/2010)|
|1.||Activated Protein C Resistance (APC Resistance)
02/01/2005 - "Antithrombin (AT) assays were shown to vary in their sensitivity to different molecular defects in the antithrombin gene; 77% of centers employing human thrombin-based activity assays reported a normal AT level in a patient with antithrombin Cambridge II. Sensitivity of the APC resistance test in the absence of factor V-deficient plasma was shown to be improved through normalization of results, and errors in the genetic diagnosis of factor V Leiden and the P20210A prothrombin gene mutation are described. "
03/01/2009 - "In this study we evaluated the role in myocardial infarction (MI) of a relatively common mutation affecting antithrombin gene (A384S: Antithrombin Cambridge II) that has functional features that may impair the right control of thrombogenic events caused by injury to the vascular wall. "
|4.||Venous Thrombosis (Deep-Vein Thrombosis)
02/01/2008 - "Antithrombin Cambridge II mutation as a risk factor to develop cerebral venous thrombosis."
05/15/2007 - "Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis."
09/01/2010 - "Antithrombin Cambridge II(A384S) mutation frequency and antithrombin activity levels in 120 of deep venous thrombosis and 150 of cerebral infarction patients in a single center in Southern China."
11/01/2008 - "Relation between the antithrombin Cambridge II mutation, the risk of venous thrombosis, and the endogenous thrombin generation."
|2.||Prothrombin (Factor II)
|3.||Factor V (Coagulation Factor V)
|4.||factor V Leiden